Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS).

Susan Torres-Harding, Matthew Sorenson, Leonard A Jason, Kevin Maher, Mary Ann Fletcher
Author Information
  1. Susan Torres-Harding: Roosevelt University.

Abstract

Few immunological markers have been consistently reported in CFS. However, a shift to a T-helper 2 (Th2) type immune response has been hypothesized for individuals with CFS. The current study investigated whether individuals with CFS who exhibited a stronger shift towards a Th2 type of immune response would also exhibit more severe symptoms, poorer neurocognitive functioning, and poorer physical and psychosocial functioning. The current investigation measured the percentage of Th1-like and Th2-like memory cells using cell surface flow cytometry in 114 individuals with CFS. The associations between the ratio of Th1 and Th2 memory cells and various illness parameters measures were then examined, including symptom severity, psychiatric functioning, neurocognitive functioning, salivary cortisol levels, and chronic pain status. Results indicated that individuals who exhibited a more extreme shift towards a Th2 immune response also exhibited poorer sleep and high levels of basal salivary cortisol. The implications of these findings are discussed.

References

  1. Brain Behav Immun. 2003 Feb;17 Suppl 1:S119-24 [PMID: 12615197]
  2. Psychiatry Res. 1989 May;28(2):193-213 [PMID: 2748771]
  3. Med Care. 1994 Jan;32(1):40-66 [PMID: 8277801]
  4. Am J Psychiatry. 1997 Mar;154(3):408-14 [PMID: 9054791]
  5. Health Qual Life Outcomes. 2003 Oct 23;1:60 [PMID: 14613562]
  6. Clin Exp Immunol. 2004 Feb;135(2):294-302 [PMID: 14738459]
  7. Clin Infect Dis. 1994 Jan;18 Suppl 1:S147-53 [PMID: 8148443]
  8. Ann Acad Med Singap. 1994 Mar;23(2):129-38 [PMID: 8080219]
  9. Pediatrics. 2006 May;117(5):e878-86 [PMID: 16618789]
  10. Ann N Y Acad Sci. 2002 Jun;966:20-7 [PMID: 12114255]
  11. Ann N Y Acad Sci. 2006 Jul;1071:221-30 [PMID: 16891573]
  12. J Endocrinol Invest. 2004 Apr;27(4):380-6 [PMID: 15233561]
  13. Diagn Clin Immunol. 1987;5(2):69-81 [PMID: 3113759]
  14. Clin Diagn Lab Immunol. 2001 May;8(3):658-62 [PMID: 11329477]
  15. Clin Diagn Lab Immunol. 2002 Jul;9(4):747-52 [PMID: 12093668]
  16. MMWR Recomm Rep. 1997 Jan 10;46(RR-2):1-29 [PMID: 9011774]
  17. Brain Behav Immun. 2001 Dec;15(4):340-70 [PMID: 11782103]
  18. Arch Neurol. 1989 Oct;46(10):1121-3 [PMID: 2803071]
  19. Med Care. 1993 Mar;31(3):247-63 [PMID: 8450681]
  20. Allergy. 2005 Jun;60(6):780-7 [PMID: 15876308]
  21. J Clin Endocrinol Metab. 2005 May;90(5):3106-14 [PMID: 15728214]
  22. J Health Soc Behav. 1983 Dec;24(4):385-96 [PMID: 6668417]
  23. J Abnorm Psychol. 1995 Aug;104(3):542-5 [PMID: 7673579]
  24. Ann Intern Med. 1994 Dec 15;121(12):953-9 [PMID: 7978722]
  25. Med Care. 1992 Jun;30(6):473-83 [PMID: 1593914]
  26. Sleep Med Rev. 2002 Apr;6(2):125-38 [PMID: 12531148]
  27. Brain Behav Immun. 2001 Mar;15(1):7-24 [PMID: 11259077]
  28. J Neuropsychiatry Clin Neurosci. 1993 Spring;5(2):200-5 [PMID: 8508039]
  29. J Infect Dis. 1996 Feb;173(2):460-3 [PMID: 8568312]
  30. J Clin Microbiol. 1990 Jun;28(6):1403-10 [PMID: 2166084]
  31. Psychiatr Clin North Am. 1996 Sep;19(3):549-73 [PMID: 8856816]
  32. Am J Med. 1996 Oct;101(4):364-70 [PMID: 8873506]
  33. Immunology. 1996 Feb;87(2):186-90 [PMID: 8698378]
  34. Int Rev Neurobiol. 2002;52:93-131 [PMID: 12498102]
  35. Neurotoxicol Teratol. 1992 Mar-Apr;14(2):103-10 [PMID: 1593984]
  36. Ann N Y Acad Sci. 1998 May 1;840:586-90 [PMID: 9629285]
  37. Brain Behav Immun. 2004 Jul;18(4):368-74 [PMID: 15157954]
  38. J Affect Disord. 1996 Jun 20;39(1):21-30 [PMID: 8835650]
  39. Appl Neuropsychol. 2001;8(1):51-64 [PMID: 11388124]
  40. Psychol Med. 2000 Jul;30(4):849-56 [PMID: 11037093]
  41. Clin J Pain. 2004 Sep-Oct;20(5):309-18 [PMID: 15322437]

Grants

  1. R01 AI049720/NIAID NIH HHS
  2. R01 AI049720-01/NIAID NIH HHS

Word Cloud

Created with Highcharts 10.0.0CFSshiftTh2individualsfunctioningimmuneresponseexhibitedpoorerT-helper2typecurrenttowardsalsoneurocognitivememorycellsillnessparameterssalivarycortisollevelschronicimmunologicalmarkersconsistentlyreportedHoweverhypothesizedstudyinvestigatedwhetherstrongerexhibitseveresymptomsphysicalpsychosocialinvestigationmeasuredpercentageTh1-likeTh2-likeusingcellsurfaceflowcytometry114associationsratioTh1variousmeasuresexaminedincludingsymptomseveritypsychiatricpainstatusResultsindicatedextremesleephighbasalimplicationsfindingsdiscussedEvidenceassociationfatiguesyndrome

Similar Articles

Cited By